Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel

doi:10.3748/wjg.v16.i14.1696

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 14

This Article

(0)

(5262)

(13)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Topic Highlight

World J Gastroenterol. Apr 14, 2010; 16(14): 1696-1706
Published online Apr 14, 2010. doi: 10.3748/wjg.v16.i14.1696

Full Size Figure Download Figure

Figure 1 Management algorithm for patients with non metastatic well-differentiated endocrine carcinoma of the small bowel (stage I-III of TNM classification). 5HIAA: 5-hydroxyindoleacetic acid.

Citation: Poncet G, Faucheron JL, Walter T. Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel. World J Gastroenterol 2010; 16(14): 1696-1706
URL: https://www.wjgnet.com/1007-9327/full/v16/i14/1696.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i14.1696

Poncet G, Faucheron JL, Walter T. Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel. World J Gastroenterol 2010; 16(14): 1696-1706 [PMID: 20380000 DOI: 10.3748/wjg.v16.i14.1696]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.